# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-245269
Filing Date
2022-09-15
Accepted
2022-09-15 09:12:00
Documents
20
Period of Report
2022-09-15

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 6-K | d336846d6k.htm | 6-K | 9757
2 | EX-99.1 | d336846dex991.htm | EX-99.1 | 24085
3 | GRAPHIC | g336846ex99_1p10g1.jpg | GRAPHIC | 275416
4 | GRAPHIC | g336846ex99_1p11g1.jpg | GRAPHIC | 243628
5 | GRAPHIC | g336846ex99_1p12g1.jpg | GRAPHIC | 324745
6 | GRAPHIC | g336846ex99_1p13g1.jpg | GRAPHIC | 262386
7 | GRAPHIC | g336846ex99_1p14g1.jpg | GRAPHIC | 299315
8 | GRAPHIC | g336846ex99_1p15g1.jpg | GRAPHIC | 262081
9 | GRAPHIC | g336846ex99_1p16g1.jpg | GRAPHIC | 273496
10 | GRAPHIC | g336846ex99_1p17g1.jpg | GRAPHIC | 448750
11 | GRAPHIC | g336846ex99_1p18g1.jpg | GRAPHIC | 80366
12 | GRAPHIC | g336846ex99_1p1g1.jpg | GRAPHIC | 187429
13 | GRAPHIC | g336846ex99_1p2g1.jpg | GRAPHIC | 458941
14 | GRAPHIC | g336846ex99_1p3g1.jpg | GRAPHIC | 309023
15 | GRAPHIC | g336846ex99_1p4g1.jpg | GRAPHIC | 259193
16 | GRAPHIC | g336846ex99_1p5g1.jpg | GRAPHIC | 315801
17 | GRAPHIC | g336846ex99_1p6g1.jpg | GRAPHIC | 278780
18 | GRAPHIC | g336846ex99_1p7g1.jpg | GRAPHIC | 292096
19 | GRAPHIC | g336846ex99_1p8g1.jpg | GRAPHIC | 242218
20 | GRAPHIC | g336846ex99_1p9g1.jpg | GRAPHIC | 262934
| Complete submission text file | 0001193125-22-245269.txt |  | 7028701

Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 221244728
SIC: 2834 Pharmaceutical Preparations